New cocktail of drugs targets Hard-to-Treat pancreatic cancer
Disease control
Recruiting now
This early-phase trial tests a combination of three drugs—regorafenib, toripalimab, and albumin-bound paclitaxel—as a third-line treatment for people with advanced pancreatic cancer that has spread or cannot be removed. The study aims to find the safest dose and see if the combo …
Phase: PHASE1, PHASE2 • Sponsor: Junjie Hang • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC